Abstract:OBJECTIVE Povidone/Copovidone were used as the main osmopolymers instead of Poly (ethylene oxide) (PEO) to prepare nifedipine controlled-release tablets of new osmotic pump type. The pharmacokinetic properties of nifedipine controlled-release tablets after multiple doses in healthy volunteers were studied, and the relative bioavailability of the test preparation was calculated and the bioequivalence was evaluated. METHODS Twenty four male healthy volunteers were enrolled in a randomized two-way crossover design. 30 mg nifedipine was administered per day during consecutive 7 d. The drug concentration in blood was determined with LC-MS/MS method. The pharmacokinetic parameters, relative bioavailability and the bioequivalence were calculated by DAS program. RESULTS The main pharmacokinetic parameters after multiple doses of test preparation and reference preparation were as follows:T1/2β (9.0±2.2)h and (9.5±3.8)h; Tmax (8.1±7.4)h and (6.7±4.1)h; Cssmax (52.7±28.2)μg·L-1 and (44.5±22.6)μg·L-1; Cssmin (29.4±22.2)μg·L-1 and (28.7±15.8)μg·L-1; AUC0-60 (1 087.4±671.6)μg·L-1·h and (1 040.2±518.4)μg·L-1·h; AUC0-∞ (1 113.1±677.2)μg·L-1·h and (1 074.5±519.8)μg·L-1·h , AUCSS (809.1±454.0)μg·L-1·h and (713.9±382.2)μg·L-1·h. The average relative bioavailability of the test preparation versus the reference preparation was as follows: FAUCss (115.2±29.2)%, FAUC0-60 (103.4±30.2)% and FAUC0-∞ (102.2±29.7)%. DF was (77.84±52.09)% and (55.48±30.54)%. The 90% confidence interval of Cmax, AUC0-60, AUC0-∞ and AUCss after longarithmic transform was (100.9-126.0)%, (87.5-111.8)%, (86.8-110.3)% and (98.8-124.4)% respectively. There was no significant difference in Tmax after non-parameter rank sum test. No adverse reaction was observed during the trial. CONCLUSION The test preparation was bioequivalent to the reference preparation. Povidone/Copovidone could replace PEO used as the main functional excipient of osmotic pump type controlled-release preparations.

Preparation of nifedipine liposomes by pH steps degree-freeze thawing method

Study on the Preparation of nifedipine liposomes

Preparation and Characterization of Nanoliposomes Entrapping Medium-Chain Fatty Acids and Vitamin C by Lyophilization

Preparation of nitrendipine liposomes and determination of encapsulation efficiency

A Liposomal Formulation for Improving Solubility and Oral Bioavailability of Nifedipine

Preparation and Quality Control of Nifedipine Cream

Study on the Capsules of Nifedipine in the Form of the Solid Dispersion

Preparation Technique and Dissolution Rate of Nifedipine Sustained-release Hydrogels

Preparation and Quality Evaluation of Irinotecan Hydrochloride Lyophilized Liposomes

Study on artwork gelsiecation of flexible nano-liposomes carrying amlodipine besylate

Preparation of Nifidipine Pulsatile Release Tablets

Preparation of Neferine-Loaded PLGA Nanoparticles Using Precipitation Method

Preparation of Nimodipine Microemulsion and Its Quality Evaluation

Pharmacokinetics and Bioequivalence Study of Nifedipine Controlled-release Tablets after Multiple Doses Administration in Healthy Volunteers

Preparation of Neferine Nanoparticles by Modified Self-Emulsion Solvent Diffusion Method

In-situ freeze-drying - forming amorphous solids directly within capsules: An investigation of dissolution enhancement for a poorly soluble drug

Nimodipine Loaded Lipid Nanospheres Prepared by Solvent Diffusion Method in a Drug Saturated Aqueous System

The Preparation of Florfenicol-Liposomes and Its Properties

Preparation and quality evaluation of drug loading transfersomes

Preparation and in vitro evaluation of nifedipine controlled-release coated pellets

Preparation Technology of Sinomenine Hydrochloride Liposomes